EICHORCondition: Attention Deficit Hyperactivity Disorder · ADHD · Sponsor: Rhodes Pharmaceuticals, L.P.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This multi-center parallel study is designed to study the efficacy and safety of fixed doses of methylphenidate extended release (ER) capsules of four dose levels compared with a placebo group in pediatric patients with Attention Deficit Hyperactivity Disorder (ADHD) who are between 6 and 18 years old.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Males and females ages 6 up to 18 * ADHD diagnosis with ADHD Rating Scale - 4th Edition scores ≥ 90th percentile * In need of treatment for ADHD and able to have 2-day washout from previous medication * Females of child-bearing potential not pregnant and practice birth control * Subject and parent/guardian willing to comply with protocol * Signed consent and assent Exclusion Criteria: * Estimated Full Scale intellectual level below 80 using Wechsler Abbreviated Scale of Intelligence (WASI) * Current primary psychiatric diagnosis of other listed disorders * Chronic medical illnesses: seizure, hypertension, thyroid disease, cardiac, family history of sudden death, glaucoma * Use of psychotropic central nervous system (CNS) meds having effect exceeding 14 days from screening * Planned use of prohibited drugs * Is pregnant or breast-feeding * Significant ECG or laboratory abnormalities * Experimental drug or medical device within 30 days prior to screening * Hypersensitivity to methylphenidate * Inability or unwillingness to comply with protocol * Well controlled on current ADHD treatment * Inability to take oral capsules
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Clinical Study Centers, LLC | Little Rock, Arkansas, United States | — |
| University of California, Irvine/Child Development Center | Irvine, California, United States | — |
| Synergy Research | National City, California, United States | — |
| Florida Clinical Research Center, LLC | Bradenton, Florida, United States | — |
| Behavioral Clinical Research, Inc. | Lauderhill, Florida, United States | — |
| Martin Kane, DO | Maitland, Florida, United States | — |
| Segal Institute for clinical Research, North Miami Outpatient Clinic | North Miami, Florida, United States | — |
| South Shore Psychiatric Services, PC | Marshfield, Massachusetts, United States | — |
| Precise Research Center | Madison, Mississippi, United States | — |
| Center for Psychiatry and Behavioural Medicine Inc | Las Vegas, Nevada, United States | — |
| New York State Psychiatric Institute/Columbia University | New York, New York, United States | — |
| Department of Psychiatry, Duke University Medical Center | Durham, North Carolina, United States | — |
+ 4 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01239030